Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of ATX-101 for Submental Fat
NCT02163902Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fat, sponsored by Kythera Biopharmaceuticals. Started Dec 2013; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT02163902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163902.